CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Novel CAR Immunotherapies for Pancreatic Cancer with Dr. Ryan Alexander

    CRI Fellow Ryan Alexander is developing new cellular immunotherapies for pancreatic cancer.

    March 7, 2022| Arthur N. Brodsky, PhD
  • Pancreatic Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This November for Pancreatic Cancer Awareness Month, discover the latest treatments, research insights, and our impact on…

    November 2, 2021| Gabriella Rojas
  • Gene Ogle

    Gene Ogle’s Immunotherapy Story

    Pancreatic Cancer |  Diagnosed 2009 [Enrolling in the clinical trials] was an opportunity to be able to contribute…
    April 27, 2021| CRI Staff
  • Dr. Elizabeth M. Jaffee Answers Questions on Pancreatic Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit

    Dr. Elizabeth Jaffee answers questions on immunotherapy for pancreatic cancer from the 2020 CRI Virtual Immunotherapy Patient…

    January 15, 2021| CRI Staff
  • CRI-Funded Trial Highlights New Hope Against Pancreatic Cancer

    New publication from the CRI PRINCE trial highlights benefits of an immunotherapy-chemotherapy combination against advanced pancreatic cancer.

    January 6, 2021| Arthur N. Brodsky, PhD
  • Pancreatic Cancer Awareness Month: 2020 Immunotherapy Research Updates

    This November for Pancreatic Cancer Awareness Month, we look at new research, new treatments, and how we’re…

    November 6, 2020| CRI Staff
  • Pancreatic Cancer, Immunotherapy, and PRINCE: An Interview with Vanessa Lucey, PhD, MBA

    We spoke with Vanessa M. Lucey, PhD, MBA, about challenges of treating pancreatic cancer and promising combination therapy…

    November 22, 2019| Arthur N. Brodsky, PhD
  • Pancreatic Cancer Awareness Month: 2019 Immunotherapy Research Update

    We round up the latest immunotherapy for pancreatic cancer news and research from the scientists, physicians, and…

    November 21, 2019| CRI Staff
  • AACR17 Update: Taking Immunotherapy to the Next Level

    After cancer immunotherapy’s initial successes, new challenges are being confronted

    April 1, 2017| Arthur N. Brodsky, PhD
1 2
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute